Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenzhen trivalent inactivated influenza vaccine
- Development stage
- Unknown
- Lead developer
- Sanofi Pasteur
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Shenzhen trivalent inactivated influenza vaccine (SP Shz TIV) is an inactivated, split-virion influenza vaccine developed for the prevention of seasonal influenza. It contains antigens from three different strains of the influenza virus, as recommended by health authorities for a given flu season. The vaccine is administered intramuscularly and works by stimulating the immune system to produce antibodies against the included viral strains, thereby providing protection against infection. This formulation is produced by companies based in Shenzhen, China and has been evaluated for safety and immunogenicity in clinical trials involving various age groups[1].
- Other names
- SP Shz TIV
02
Targets
HA (Hemagglutinin)
Beyond the preview
Go deeper on Shenzhen trivalent inactivated influenza vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenzhen trivalent inactivated influenza vaccine.